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Conclusions. Management and individualized treatment of hepatic fibrosis depend on 
establishing an accurate stage diagnosis. Non-invasive methods, serum biomarkers and 
imaging techniques allow to determine a correct diagnosis and at the same time to minimize 
the complications. FibroTest, FibroScan and APRI score are methods that showed the highest 
clinical efficiency. However, recent studies are focused on identifying the correlation between 
tissue modifications, the results of serum biomarkers and FibroTest, FibroScan and APRI 
score.   
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Introduction. Cholecystokinin (CCK) is a peptide hormone that, together with secretin and 
gastrin, forms the triad of intestinal hormones. Due to the receptors, which are expressed in 
different tissues, and to the diversity of the subgroups of the cholecystokinin family peptides 
that activates them, CCK acts on different organs and systems.  
Aim of the study. Identification and study of the biochemical and physiological effects of the 
subgroups of the CCK peptides family and of their role in maintaining homeostasis and 
viability of the human organism.  
Materials and methods. A bibliographic study of the specialized literature present in the 
databases PubMed, MeSH, Internet Archive, IUPHAR/BPS, from 2010-2020 was performed, 
using the search words cholecystokinin, CCK receptors, expression of CCK receptors, 
cholecystokinin-like peptides, physiology of the Gastrointestinal Tract.  
Results. There are two types of CCK receptors: CCK-A (CCK1 "Alimentary") and CCK-B 
(CCK2 "Brain"). CCK-A receptors are located in the gall bladder where stimulates its 
contractions, in the intestinal parietal mucosa where via somatostatin inhibits gastric acid 
secretion, in the nervous system where directly or indirectly, through dopaminergic processes, 
it modulates the behavior in general and eating behavior in particular. CCK-B receptors are 
predominantly in the CNS where they modulate anxiety, analgesia and neuroleptic activities. 
CCK-B receptors also have been identified in the pancreas where they stimulate the secretion 
of enzymes. It has been shown that pancreas-responsible neurons release CCK-8 and CCK-5, 
which subsequently produce effects. Moreover, CCK via acetylcholine activates 
parasympathetic neurons, therefore increasing blood supply to the stomach and increasing 
motility. At the thyroid level, CCK-8 stimulates normal growth and C-cell proliferation.   
Conclusions. The expression of CCK at the level of different organs determines a wide range 
of various effects, involved in normal metabolic and physiological processes, which ensures 
the maintenance of homeostasis and viability of organs and tissues. Knowledge of the 
pleiotropic effects of the CCK family peptides and the receptors involved in their development 
opens new possibilities for addressing the nutritional disorders and functional diseases of the 
gastrointestinal tract, as well as of intervention in some processes in the nervous system 
associated with chronic pain, anxiety and depression.  
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